CPI Aerostructures Inc (CVU)
AMEXIndustrialsAerospace & DefenseSnapshot 2026-09-04
$5.16+1.38%
Close 2026-09-04 · 1-day change
AMEXIndustrialsAerospace & DefenseSnapshot 2026-09-04
QuarterlyIQ Insights · CVU
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 4 valuation methods, at three horizons. As of 2026-09-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $5.16 CVU trades at 0.9× p/s, below its 3.3× p/s peer median, but our blended $3.69 fair value sits well below the price. We hold it with low confidence: its earnings are too depressed to value on P/E (we anchor on sales instead) and the peer anchor overstates how cheap it looks. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer EV/EBITDA | 12M | $4.86 | 27.6 | 0.23 | TTM | high |
| Peer P/E | 12M | $1.21 | 30.2 | 0.04 | TTM | high |
| Peer P/S | 12M | $18.60 | 3.3 | 5.64 | TTM | high |
| triangulated | 12M | $1.23 | 30.2 | 0.04 | Triangulated | high |
| Peer P/E | 3Y |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 15% over what the business is worth with no growth; closing that gap needs roughly 3.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $0.27/sh owner earnings.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $14.52 |
| 30.2 |
| 0.48 |
| Hist. CAGR(prov.) |
| medium |
| Peer P/S | 3Y | $18.86 | 3.3 | 5.72 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $13.01 | 30.2 | 0.43 | Hist. CAGR(prov.) | medium |
| Peer P/S | 5Y | $16.89 | 3.3 | 5.13 | Hist. CAGR(prov.) | medium |